Johnson & Johnson: Der alte Dampfer liefert ab
Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…
177,582$
-0,23%
Echtzeit-Aktienkurs Johnson & Johnson
Bid:
Ask:
Nachrichten zur Johnson & Johnson Aktie
United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
The United States Pharmaceutical Market is projected to reach $979.25 billion by 2033, from $638.86 billion in 2024, at a…
Protagonist (PTGX) Q2 Revenue Falls 26%
Key PointsGAAP loss per share of $0.55 in Q2 2025 beat analyst estimates by $1.13.GAAP revenue of $5.5 million in…
Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
Manning, Johnson Controls VP, sells $147k in shares By Investing.com
Manning, Johnson Controls VP, sells $147k in shares…
Why Johnson & Johnson Stock Still Has Room To Run
…
Johnson Outdoors (JOUT) Q3 EPS Soars
Key PointsEarnings per share (GAAP) jumped to $0.75 in Q3 FY2025, beating the analyst estimate of $0.24 (GAAP) by $0.51.Revenue…
Eli Lilly, Pfizer und Johnson & Johnson im Visier der US-Regierung und auch Novo Nordisk hat momentan wenig zu lachen
Das Geschäftsmodell der großen Pharmakonzerne ist nicht nur weitgehend krisensicher, sondern auch enorm lukrativ. Zu verdanken ist dies zu nicht…
Bosch: Milliarden-Übernahme in den USA, Kauf der Klimatechnik-Sparte von Johnson Controls
Das deutsche Unternehmen Bosch übernimmt die Klimatechniksparte von Johnson Controls für acht Milliarden Dollar, der größte Zukauf in der Unternehmensgeschichte.…
Johnson Outdoors Reports Fiscal Third Quarter Results
RACINE, Wis., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq:JOUT), a leading global innovator of outdoor…
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.
Key PointsReliability is one of the most important things about a dividend.Johnson & Johnson is a Dividend King with an…
Is the Stock Market in Bubble Territory?
Valuations are stretched, but is it a bubble? In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel…
JNJ Seeks FDA Approval for Oral Psoriasis Drug Icotrokinra
Johnson & Johnson eyes FDA nod to icotrokinra after phase III studies show strong skin clearance and safety in plaque…
Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
Spravato sales momentum underscores market potential for psychedelics, atai Life Sciences seen as key beneficiary
Sales of Johnson & Johnson (NYSE:JNJ)’s esketamine nasal spray Spravato grew sequentially in the second quarter, marking a positive sign for…
Johnson Controls secures $377.9M contract for automation systems By Investing.com
Johnson Controls secures $377.9M contract for automation systems…
Johnson & Johnson Aktie: Wachstum bei "Innovative Medicine" dürfte Prognosen übertreffen
San Francisco (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Wells Fargo Advisors:
Die Analysten von Wells Fargo haben das Rating "equal-weight" und…
Johnson & Johnson: The Worst Is Baked In
…
Johnson & Johnson Aktie: Morgan Stanley erhöht Kursziel - aber kein Kauf?
Bad Marienberg (www.aktiencheck.de) - Johnson & Johnson: Kursziel steigt auf 176 USD – Analyst bleibt dennoch zurückhaltend
Die Investmentbank Morgan Stanley…
Johnson & Johnsons Healthy 3.3%-Yielding Dividend Is a Very Safe Way to Make Passive Income @themotleyfool #stocks $JNJ $^GSPC
…
Johnson & Johnsons Healthy 3.3%-Yielding Dividend Is a Very Safe Way to Make Passive Income
Key PointsJohnson & Johnson continues to generate plenty of free cash flow to cover its dividend. The healthcare giant also…
Is Johnson & Johnson a Good Dividend Stock to Buy Now? @themotleyfool #stocks $JNJ
…
Johnson & Johnson überrascht mit starken Quartalszahlen! Pharma-Gigant trotzt Stelara-Verlust und Zolldrohung!
Johnson & Johnson (i)(JNJ) zählt zu den führenden Gesundheitskonzernen weltweit – mit einem starken Portfolio in Pharmazeutik und Medizintechnik. Trotz…
Caverion Finland agrees asset transfer of the Johnson Controls Finland service and maintenance business.
Caverion Press release, 16 July 2025 at 09:00 CET
The companies have committed to strengthening their existing partnership in industrial refrigeration…
Caverion Finland agrees asset transfer of the Johnson Controls Finland service and maintenance business
Press release
17 July 2025 at 09:00 CET
Caverion Suomi Oy and Johnson Controls Finland Oy have signed an agreement whereby Caverion…
3 Top Dividend Stocks Yielding More Than 3% That You Shouldnt Hesitate to Buy Right Now
Key PointsExxonMobil has the best dividend growth track record in the oil industry. Johnson & Johnson has increased its dividend…
Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript
…
Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025.…
Johnson & Johnson (JNJ) Surpasses Q2 Earnings and Revenue Estimates
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025.…
Johnson & Johnson Lifts 2025 Outlook
Johnson & Johnson (NYSE:JNJ) reported Q2 2025 earnings on July 16, 2025, posting sales of $23.7 billion (up 4.6%), with…
Why Johnson & Johnson Rallied Today
Key PointsJohnson & Johnson delivered a "beat and raise" quarter. Results were bolstered by the new acquisition of Intra-Cellular, marking…
Johnson & Johnson Tops Q2 Estimates
Key PointsAdjusted EPS reached $2.77 in Q2, topping estimates by $0.09, but fell year over year.Revenue rose 5.8% year over…
Dows 110-point rally highlighted by gains in Johnson & Johnson, Amgen shares
The Dow Jones Industrial Average is up Wednesday afternoon with shares of Johnson & Johnson and Amgen seeing positive momentum…
Stocks making the biggest moves midday: Morgan Stanley, ASML, Johnson & Johnson, SolarEdge and more
These are the stocks posting the largest moves in midday trading.…
Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
DATEWednesday, July 16, 2025 at 8:30 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Joaquin DuatoChief…
Johnson & Johnson Q2 Earnings Review: This Is As Safe As Pharma Investing Gets
…
Wall Street: Nvidia und Johnson & Johnson stehen zum Auftakt im Fokus
Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…
Wall Street: Nvidia und Johnson & Johnson stehen zum Auftakt im Fokus
Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…
Market movers: Johnson & Johnson, Morgan Stanley, Bit Digital...
…
Johnson & Johnson (JNJ) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Johnson & Johnson (JNJ) give insight into how the company performed in the quarter ended June…
Johnson & Johnson Aktie: Zölle wohl doch nicht so schlimm
Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…
Geschäfte mit Medizintechnik treibt Johnson & Johnson an - Prognosen angehoben
NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) blickt nach einem überraschend guten zweiten…
Geschäfte mit Medizintechnik treibt Johnson & Johnson an - Prognosen angehoben
NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) blickt nach einem überraschend guten zweiten Quartal zuversichtlicher auf das…
Stocks making the biggest moves premarket: Goldman Sachs, ASML, Diageo, Johnson & Johnson and more
These are the stocks posting the largest moves in premarket trading.…
3 Magnificent S&P 500 Dividend Stocks Down 16% to 20% to Buy and Hold Forever
Key PointsDividend stocks are one of the most powerful investing tools to build wealth. The S&P 500 has plenty of…
Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales
Johnson & Johnson reported second-quarter profit and raised its full-year sales forecast by around $2 billion on Wednesday as strong…
Johnson & Johnson delivers earnings beat, raises full year sales and profit guidance
Johnson & Johnson (NYSE:JNJ) shares edged higher premarket as the healthcare firm reported an earnings beat for the second quarter…
Johnson Controls names Chris Scalia as new HR chief By Investing.com
Johnson Controls names Chris Scalia as new HR chief…
10 Dividend Stocks to Double Up On Right Now
Key PointsDividend stocks have historically outperformed non-dividend payers. Several companies have excellent records of paying a growing dividend. Theyre worth…
Want to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock.
Key PointsKenvue is spending big to drum up demand for its diversified product portfolio.The companys weak results reflect pressure on…